Cited by 850Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Open access

Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J., Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo·2014·Neurology

DOI 10.1212/wnl.0000000000000101PMC PMC3937859

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/215) were positive for MOG antibodies and 64.7% (139/215) were positive for AQP4 antibodies. No patients were positive for both antibodies. Patients with MOG antibodies represented 21.1% (16/76) of the patients negative for AQP4 antibodies. Compared with patients with AQP4 antibodies or patients who were seronegative, patients with MOG antibodies were more frequently male, had a more restricted phenotype (optic nerve more than spinal cord), more frequently had bilateral simultaneous optic neuritis, more often had a single attack, had spinal cord lesions distributed in the lower portion of the spinal cord, and usually demonstrated better functional recovery after an attack. CONCLUSIONS: Patients with NMOSD with MOG antibodies have distinct clinical features, fewer attacks, and better recovery than patients with AQP4 antibodies or patients seronegative for both antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000101

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. E., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,819
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Mader, S., Gredler, V., Schanda, K., Rostasy, K. M., Dujmović, I., Pfaller, K., Lutterotti, A., Jarius, S., Pauli, F. D., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O’Connor, K. C., McLaughlin, K. A., Jager, P. L. D., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar‐Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 419
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Show all 21 references

Sorted by citations

Items 601–700 of 848

A case report on recurrent area postrema syndrome in AQP4-IgG-positive NMOSD
Shrestha, R., & Kharel, G. (2022) · Oxford Medical Case Reports · doi:10.1093/omcr/omac109 · Cited by 4
FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with seizure following SARS-CoV-2 mRNA vaccination
Yoshino, F., Ozaki, Y., Shibahara, T., Matsuoka, M., Tachibana, M., Ago, T., Kitazono, T., Kuroda, J., & Nakane, H. (2023) · eNeurologicalSci · doi:10.1016/j.ensci.2023.100492 · Cited by 4
Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022
Jiang, B., Hong, N., Zhao, F., & Dong, F. (2024) · International Ophthalmology · doi:10.1007/s10792-024-02948-7 · Cited by 5
Antibodies in acquired demyelinating disorders in children
Armangué, T., Yeshokumar, A. K., Sepúlveda, M., Graus, F., & Saiz, A. (2016) · Multiple Sclerosis and Demyelinating Disorders · doi:10.1186/s40893-016-0008-9 · Cited by 4
OCT Findings in Neuromyelitis Optica Spectrum Disorders
Outteryck, O., & Vermersch, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-20970-8_6 · Cited by 4
NEUROMYELITIS OPTICA SPECTRUM DISORDERS: DIAGNOSIS AND TREATMENT, THE EXPERIENCE OF CLINICAL OBSERVATIONS
Piven, V. D., Сергеевич, К. В., Novikova, A. S., Piven, F. M., Kushnir, Y. B., & Тотолян, Н. А. (2018) · The Scientific Notes of the Pavlov University · doi:10.24884/1607-4181-2018-25-3-7-13 · Cited by 4
B cells in autoimmune diseases of the central nervous system
Noto, D., & Miyake, S. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12603 · Cited by 4
Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre
Armindo, R. D., Pinto, J., Pereira, C., Vasconcelos, M., & Palavra, F. (2020) · European Neurology · doi:10.1159/000508070 · Cited by 4
Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients
He, M., Wu, L., Huang, D., & Yu, S. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102459 · Cited by 4
Comparison of Optic Neuritis with Seropositive Myelin Oligodendrocyte Glycoprotein Antibody and Seropositive Neuromyelitis Optica Antibody
Kang, M. C., & Park, K. (2021) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2021.62.4.538 · Cited by 4
The frequency of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-IgG-negative neuromyelitis optica spectrum disorders patients in Latin America
Contentti, E. C., López, P. A., & Rojas, J. I. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103122 · Cited by 4
Evolution in anti-myelin oligodendrocyte glycoprotein antibody detection and its clinical significance: a narrative review
Zhong, X., Wang, Y., Luo, W., Ma, X., Sun, X., Jiang, B., & Qiu, W. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4547 · Cited by 4
Anti-Myelin Oligodendrocyte Glycoprotein (MOG) antibody disease presenting with severe dystonia
Khan, T. R., Waugh, J. L., & Wang, C. (2021) · Neuroimmunology Reports · doi:10.1016/j.nerep.2021.100038 · Cited by 4
Epidemiología del espectro de neuromielitis óptica. Nuevos y viejos desafíos
Gázquez, M. S., Arrambide, G., & Cobo‐Calvo, Á. (2021) · Revista de Neurología · doi:10.33588/rn.7401.2021163 · Cited by 4
A Comparative Analysis of Clinical and Imaging Features of Aquaporin 4 (AQP4) Antibody Positive, Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive and Double Seronegative Subtypes of Neuro Myelitis Optica Spectrum Disorder (NMOSD)
Gupta, S. K., Rehani, V., Dhull, P., Somasekharan, M., & Sreen, A. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_406_21 · Cited by 4
Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview
Misu, T., Matsumoto, Y., Kaneko, K., Takahashi, T., Takai, Y., Ono, H., Namatame, C., Nishiyama, S., Fujimori, J., Kuroda, H., et al. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12771 · Cited by 4
Experience with newer central nervous system autoantibodies
Karim, A., & Jacob, S. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217724818 · Cited by 4
Three Japanese adult cases of brain lesions with anti‐myelin oligodendrocyte glycoprotein antibodies lacking optic neuritis and myelitis
Sawada, J., Katayama, T., Toyoshima, S., Nitamizu, S., Yamamoto, K., Fukuura, A., Kikuchi, S., Kano, K., Asanome, A., Takahashi, K., et al. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12459 · Cited by 4
Neuromyelitis optica spectrum disorder: an overview
Ramakrishnan, P., & Nagarajan, D. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-023 · Cited by 5
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management
Hur, M. H. (2021) · Pediatric Annals · doi:10.3928/19382359-20210519-03 · Cited by 4
A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
Morris, K. A., Waters, P. J., Woodhall, M. R., Küker, W., Vincent, A. C., Leite, M. I., & Sen, A. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000088 · Cited by 4
Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica
Domingo‐Santos, A., Sepúlveda, M., Matarazzo, M., Calleja, P., Ramos‐González, A., Saiz, A., & Benito‐León, J. (2016) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000176 · Cited by 4
NMO Spectrum Disorders
Pfeuffer, S., Strippel, C., & Wiendl, H. (2017) · Neurology International Open · doi:10.1055/s-0043-102456 · Cited by 4
Optische Kohärenztomographie bei Neuromyelitis optica-Spektrum-Erkrankungen
Oertel, F. C., Zimmermann, H. G., Brandt, A. U., & Paul, F. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0444-6 · Cited by 4
Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia
Fabis‐Pedrini, M. J., Bundell, C. S., Wee, C. K., Lucas, M., McLean‐Tooke, A. P., Mastaglia, F. L., Carroll, W. M., & Kermode, A. G. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.006 · Cited by 4
Potential Pathological Biomarkers in Multiple SclerosisPreprint
Mathur, D., Rout, S., Mishra, B., Rodas, G., Vallamkondu, J., Kandimalla, R., & Casanova, B. (2020) · Preprints.org · doi:10.20944/preprints202009.0293.v1 · Cited by 1
Decoding paraneoplastic neuromyelitis optica: a multi-omics investigation of tumor-driven T and B cell dynamics
Huang, W., Lin, R., Zeng, X., Wang, H., & Yan, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1665688 · Cited by 4
Limited availability of live CBA for AQP4-IgG testing and its consequences for the diagnosis and treatment of NMOSD in Latin American countries
Boldrini, V. D. O., & Contentti, E. C. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578817 · Cited by 3
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence
Stögbauer, J., Schegerer, V., Klein, C., Pawlitzki, M., Meuth, S. G., Aktaş, O., Groppa, S., & Fousse, M. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103970 · Cited by 3
Two Cases of Juvenile Myelomonocytic Leukemia and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yamamoto, H., Natsume, J., Kaneko, K., Takahashi, T., Wakamatsu, M., Ogawa, C., Kumai, S., Suzui, R., Sawamura, F., Shiraki, A., et al. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.03.002 · Cited by 3
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study
Jiang, F., Cai, H., Li, H., Yin, W., Ouyang, S., Hu, J., Tu, E., Fu, K., Yin, J., Zhao, Z. W., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52191 · Cited by 4
Efficacy and safety of tocilizumab treatment in refractory MOG-IgG related optic neuritis
Xu, X., Wang, Y., Sun, M., Li, Y., Chen, B., Chen, X., Xu, Q., Wei, S., & Zhou, H. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241306685 · Cited by 3
MS and related disorders: looking for markers of phenotypes
Trojano, M., & Tortorella, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70291-1 · Cited by 3
Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem
Adachi, T., Yasui, K., Takahashi, T., Fujihara, K., Watanabe, Y., & Nakashima, K. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6122 · Cited by 3
Infectious, Autoimmune and Other Immune-Mediated Causes of Myelitis
Kleiter, I., Schmutzhard, E., & Trebst, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-46293-6_6 · Cited by 3
Modified models to distinguish central nervous system demyelinating diseases with brain lesions
Chen, B., Qin, C., Ji, S., Tian, D., Zhang, M., & Bu, B. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102965 · Cited by 3
Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
Kotov, S. V., Novikova, E. S., & Котов, А. С. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-4-18-24 · Cited by 3
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders
Masuda, H., Mori, M., Yokouchi, H., Uzawa, A., Uchida, T., Muto, M., Ohtani, R., Aoki, R., Yamamoto, S., & Kuwabara, S. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10764-7 · Cited by 3
Optic neuritis with potential for poor outcome
Cooper, S. A., Leddy, S. G., Skipper, N. T., Barrett, V. J. M., & Plant, G. T. (2022) · Practical Neurology · doi:10.1136/practneurol-2021-003228 · Cited by 3
Autoimmune diseases of the spine and spinal cord
Biddle, G., Beck, R. T., Raslan, O. A. A., Ebinu, J. O., Jenner, Z., Hamer, J. F., Hacein‐Bey, L., Apperson, M., & Ivanović, V. (2023) · The Neuroradiology Journal · doi:10.1177/19714009231187340 · Cited by 3
Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis
Sun, M., Liu, H., Zhu, B., Liu, Y., Li, A., & Wang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1266067 · Cited by 3
Clinical and radiological spectrum of acquired inflammatory demyelinating diseases of the central nervous system in a tertiary care center
Yellaturi, S., Sowmini, P. R., Muralidharan, K., Reddy, P. G. P. K., & Mugundhan, K. (2024) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_603_2023 · Cited by 3
Successful Maintenance Therapy with Intravenous Immunoglobulin to Reduce Relapse Attacks and Steroid Dose in a Patient with Refractory Myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis
Kamijo, Y., Usuda, M., Matsuno, A., Katoh, N., Morita, Y., Tamaru, F., Kasamatsu, H., & Sekijima, Y. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3593-24 · Cited by 3
Clinical Reasoning: A 55-year-old woman presenting with ataxia and numbness 1 year after ileum resection
Cassano, V., Spagni, G., & Iorio, R. (2019) · Neurology · doi:10.1212/wnl.0000000000008253 · Cited by 3
Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease
Warabi, Y., Takahashi, T., & Isozaki, E. (2019) · Cureus · doi:10.7759/cureus.6040 · Cited by 3
Visual impairment
Ellenberger, C. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00045-4 · Cited by 3
Myelin-Oligodendrozyten-Glykoprotein-Antikörper bei Neuritis nervi optici im Kindesalter
Tegetmeyer, H., & Merkenschlager, A. (2017) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-0043-120067 · Cited by 3
Longitudinally extensive transverse myelitis involving fifteen vertebral bodies positive for anti-myelin oligodendrocyte glycoprotein (MOG) antibody: a case report
Imai, T., Shibata, S., Shinohara, K., Sakurai, K., Horiuchi, M., & Hasegawa, Y. (2019) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001290 · Cited by 3
Bases Fisiopatológicas Del Espectro De Neuromielitis Óptica: ¿Qué Sabemos?
Claudio Meza, P., & Pilar Canales, F. (2020) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272020000200161 · Cited by 3
Acute retrobulbar optic neuritis with anti-myelin oligodendrocyte glycoprotein antibody-associated disease complicated with microscopic polyangiitis
Asano, T., Saito, Y., Matsuoka, N., Temmoku, J., Fujita, Y., Hattori, K., Kobayashi, S., Ojima, A., Takahashi, T., Matsumoto, H., et al. (2021) · Medicine · doi:10.1097/md.0000000000024889 · Cited by 3
Myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis
Eliseeva, D. D., Vasiliev, A. V., Шабалина, А. А., Simaniv, T. O., & Zakharova, M. N. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012007213 · Cited by 3
AQP4 in biopsied demyelinating lesions as a diagnostic clue to NMOSD and MS
Fujihara, K., & Misu, T. (2015) · Neurology · doi:10.1212/wnl.0000000000001135 · Cited by 3
The observations on the influence of a small dose of x-rays on the conjugating paramecia.
Komala, Z. (1968) · PubMed · Cited by 3
Inflammatory Demyelinating Diseases of the Central Nervous System
Li, M., & Liu, Q. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_8 · Cited by 3
Analysis of the initial orbital MRI in aquaporin-4 antibody-positive optic neuritis (AQP4-ON): lesion location and lesion length can be predictive of visual prognosis
Shaw, H., Feng, C., Qi, M., Deng, Y., Chen, W., Zhang, Y., Wang, L., Lin, N., Tian, G., & Sha, Y. (2024) · Neuroradiology · doi:10.1007/s00234-024-03306-1 · Cited by 2
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomes
Rechtman, A., Friedman‐Korn, T., Zamir, S., Zveik, O., Levin, N., & Vaknin‐Dembinsky, A. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106717 · Cited by 2
2025 Brazilian guidelines for the management of neuromyelitis optica spectrum disorder in adults and children
Apóstolos‐Pereira, S. L., Damasceno, A., Piccolo, A. C., Mendes, M. F., Ferreira, M. L. B., Alvarenga, R. M. P., da Costa, B. K., Sato, D. K., Brum, D. G., de Melo, E. M. V., et al. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1812471 · Cited by 2
External validation of the MOG-AR score for predicting post-attack relapse risk in a chinese cohort with MOGAD
Luo, W., Huang, Y., Du, Y., ZhangBao, J., Luo, M., Zhong, X., Tang, J., Tang, Y., Quan, C., Wu, Y., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106829 · Cited by 2
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management
Dolan, R. F., Rangu, N., Dang, D. H., & Melson, A. T. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000597 · Cited by 2
Long-Term Treatment With Interleukin-6 Receptor Inhibitor Tocilizumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Capecchi, F., Graure, M., Yasaroglu, S., Schubert, S., Nierobisch, N., Kana, V., Weller, M., Roth, P., & Herwerth, M. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000049 · Cited by 2
Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study
Kwon, S., Seo, J., Chung, Y. H., Cho, J., Kang, D., & Min, J. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125909 · Cited by 2
Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
Thatikonda, N., Gomez, J., & Toledo, E. G. (2020) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.4103/ijri.ijri_486_19 · Cited by 2
Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis
Fujimori, J., & Nakashima, I. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117528 · Cited by 2
Multiple sclerosis and neuromyelitis optica spectrum disorders
Ionescu, R.-B., Willis, C. M., Nicaise, A. M., Krzak, G., Hamel, R., Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00051-4 · Cited by 2
Neurologic autoimmune diseases
Rodríguez, Y., Restrepo, L., Chang, C. C.-C., & Anaya, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00033-3 · Cited by 2
Utility of optical coherence tomography in patients of central immune mediated demyelinating diseases – A prospective study
Vegda, M., Panda, S., & Bhatnagar, K. (2023) · eNeurologicalSci · doi:10.1016/j.ensci.2023.100464 · Cited by 2
Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice
Budhram, A., & Flanagan, E. P. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00002-5 · Cited by 3
Neurosyphilis Manifesting as a Longitudinally Extensive Transverse Myelitis: A Case Report
Bou, G., Alshaer, Q. N., Harrison, T. B., & Hutto, S. K. (2024) · The Neurohospitalist · doi:10.1177/19418744241258694 · Cited by 2
Distinct clinical patterns in AQP4-IgG- positive NMOSD patients vs. Seronegative: Insights from a single-center study in Argentina
Villa, A. M., Manín, A., Seimandi, C., Guerrero, D. A., & Ramos, G. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106223 · Cited by 2
Ten Years of Neurology ® Neuroimmunology & Neuroinflammation
Dalmau, J. O., Dalakas, M. C., Kolson, D. L., Pröbstel, A., Paul, F., & Zamvil, S. S. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200363 · Cited by 2
Novel Automated Chemiluminescent Immunoassay for the Detection of Autoantibodies Against Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders
Yamazaki, N., Takahashi, T., Misu, T., & Nishikawa, Y. (2025) · Diagnostics · doi:10.3390/diagnostics15030298 · Cited by 3
A comparative study on clinico-radiological profile, treatment responses and outcomes of double seronegative NMOSD compared to AQP4-IgG positive NMOSD, and MOGAD
Lotlikar, R. S., Nair, S. S., Prasad, A. K., Narasimhaiah, D., Thomas, B., & Sundaram, S. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106669 · Cited by 2
Double-negative NMOSD: from case report to a proposed diagnostic and therapeutic algorithm
Romano, G., Lus, G., Cirillo, M., Coppola, C., Bonavita, S., & Signoriello, E. (2025) · BMC Neurology · doi:10.1186/s12883-025-04326-x · Cited by 2
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease
Kaneko, K., Takahashi, T., Misu, T., Nakashima, I., & Fujihara, K. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12578 · Cited by 2
MOG-IgG Associated Disease (MOG-AD) in Adults
Brayo, P., & Shah, S. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00672-6 · Cited by 2
Review on Recent Advances in Multiple Sclerosis and Related Disorders
Tenembaum, S. N. (2013) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s12-016 · Cited by 2
Three cases of neuromyelitis optica spectrum disorder
Matsusue, E., Fujihara, Y., Suto, Y., Takahashi, S., Tanaka, K., Nakayasu, H., Nakamura, K., & Ogawa, T. (2016) · Acta Radiologica Open · doi:10.1177/2058460116641456 · Cited by 2
The Swollen Optic Disc in Children
Brodsky, M. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3384-6_3 · Cited by 2
Recurrent Longitudinally Extensive Myelitis and Aquaporin-4 Seronegativity – The Expanding Spectrum of Neuromyelitis Optica
Anadure, R. K. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/24186.9564 · Cited by 2
Diagnostic Challenges in Pediatric Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Banwell, B., & Yeshokumar, A. K. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1604421 · Cited by 2
Perivenous demyelination: Association with anti‐myelin oligodendrocyte glycoprotein antibody
Misu, T., Takai, Y., Takahashi, T., Nakashima, I., Fujihara, K., & Aoki, M. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12569 · Cited by 2
Diagnostic features of initial demyelinating events associated with serum MOG-IgG
Orlandi, R., Mariotto, S., Ferrari, S., Gobbin, F., Sechi, E., Capra, R., Mancinelli, C. R., Bombardi, R., Zuliani, L., Zoccarato, M., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577260 · Cited by 2
Clinical and radiological features of MS, NMOSD, and MOGAD, and evolution of the diagnostic processes in Thailand
Rattanathamsakul, N., & Siritho, S. (2021) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12489 · Cited by 2
Multiple sclerosis limited to spinal cord lesions
Takeuchi, W., Fujimori, J., & Nakashima, I. (2021) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12635 · Cited by 2
Serum Biomarkers in Neuro-Ophthalmology: When to Test
Cohen, D. A., Gise, R. A., & Gaier, E. D. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1897856 · Cited by 2
Microfluidic system evaluation for the semi-automatic detection of MOG-IgG in serum samples
Khemthongcharoen, N., Uawithya, P., Yookong, N., Chanasakulniyom, M., Jeamsaksiri, W., Sripumkhai, W., Pattamang, P., Juntasaro, E., Houngkamhang, N., Thienthong, T., et al. (2021) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2021.100458 · Cited by 2
Diagnostic pitfalls in neuromyelitis optica spectrum disorders
Jasiak-Zatońska, M., Michalak, S., Kozubski, W. P., & Kalinowska, A. (2021) · Aktualności Neurologiczne · doi:10.15557/an.2021.0019 · Cited by 1
The Diagnostic Value of Neutrophil to Lymphocyte Ratio as an Effective Biomarker for Neuromyelitis Optica Spectrum Disorder
Fazlinejad, N., Hosseini, S., Yaghoobpoor, S., Dehghani, M., Bazrafshan, H., Khanzadeh, S., & Lucke-Wold, B. P. (2023) · Journal of Physical Medicine and Rehabilitation · doi:10.33696/rehabilitation.5.035 · Cited by 2
Aspectos clínicos en el espectro deneuromielitis óptica: revisión de la literatura
Claudio Meza, P., Alejandro Henríquez, C., Andrés Jara, Q., & Pilar Canales, F. (2016) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272016000300007 · Cited by 2
Case of anti‐myelin oligodendrocyte glycoprotein antibody‐associated demyelinating disease with atopic dermatitis
Takei, K., Sato, M., Nakamura, M., Shimizu, H., & Nakashima, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12365 · Cited by 2
Neuromyelitis Optica Spectrum Disorders
Filippi, M., & Rocca, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-38621-4_3 · Cited by 2
Immune-Mediated Myelopathies: A Review of Etiologies, Diagnostic Approach, and Therapeutic Management
Abdel-Wahed, L., & Cho, T. A. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1725152 · Cited by 2
Serum negative neuromyelitis optica spectrum disorder after vaxzevria vaccination: A case report
Gorgone, G., Giudice, F. D., David, P., Franco, G. M., Giofrè, L., Grillo, G., Iellamo, M. A., Mastrandrea, C., Orlando, C., Vecchio, A., et al. (2021) · Neuroimmunology Reports · doi:10.1016/j.nerep.2021.100016 · Cited by 2
Neuromyelitis optica spectrum disorder and Sjögren syndrome are overlapping disorders and participate in the same autoimmunity context?
Pimentel, M. L. V. (2014) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20140115 · Cited by 2
Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders—Experience from Tertiary Care Center in North India
Hans, R., Prakash, S., Sharma, R. R., Sankhyan, N., Takkar, A., Goyal, M., Saikia, B., Lal, V., & Marwaha, N. (2022) · Neurology India · doi:10.4103/0028-3886.344678 · Cited by 1
MOG antibody‐related disorder associated with peripheral facial nerve palsy
Morishima, Y., Satake, A., Hata, T., Koh, K., Nagasaka, T., Takahashi, T., Shindo, K., & Takiyama, Y. (2022) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12708 · Cited by 1
Sensitivity and specificity of visual evoked potentials for early diagnosis of demyelinating diseases
Abildúa, M. J. A., Almarcha-Menargues, M. L., Lucas, C. A., Martín, G. C., Montero, C. J., Gisbert, E. S., López, C. P., & Martinez, A. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.07.005 · Cited by 1
Role of serostatus in pediatric neuromyelitis optica spectrum disorders: A nationwide multicentric study
Solmaz, İ., Öncel, I. H., Konuşkan, B., Erol, İ., Orgun, L. T., Yılmaz, Ü., Ünalp, A., Atasoy, E., Aksoy, E., Yılmaz, D., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104847 · Cited by 1
Systemic association of myelin oligodendrocyte glycoprotein antibody disease: A systematic review of literature
Porey, C., & Jaiswal, B. K. (2024) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12790 · Cited by 1
Neuromyelitis optica spectrum disorder co‐existing with antiphospholipid syndrome: A case report
Edwin, G., Msagati, F., Komanya, F. B., Alphonce, B., Meda, J. R., & Nyundo, A. (2024) · Clinical Case Reports · doi:10.1002/ccr3.8818 · Cited by 1

Authors: Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., Lino, A. M. M., Misu, T., Leite, M. I., Aoki, M., & Fujihara, K.
Affiliations: Universidade Federal de Minas Gerais (BR)
From the Departments of Neurology (D.K.S., T.T., I.N., M.A.) and Multiple Sclerosis Therapeutics (T.M., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology (D.C., F.M.d.H.J., S.L.A.-P., R.F.S., A.M.M.L.), Faculty of Medicine, University of São Paulo, Brazil; CIEM MS Research Center (M.A.L.-P., N.T.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Neuroimmunology Group (P.J.W., M.I.L.), Nuffield Department of Clinical Neurosciences,...
ORCID: Sato, Douglas Kazutoshi
Callegaro, Dagoberto
Waters, Patrick J.
Takahashi, Toshiyuki
Nakashima, Ichiro
Lino, Angelina Maria Martins
Misu, Tatsuro
Leite, Maria Isabel
Aoki, Masashi
Fujihara, Kazuo
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-02-11
Volume: 82
Issue: 6
Pages: 474-481
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000101
PMC: PMC3937859
OpenAlex: W2103812851
Cited by: 850
References: 21
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 67 · 2022: 69 · 2021: 94 · 2020: 95 · 2019: 83 · 2018: 76 · 2017: 82 · 2016: 66 · 2015: 66 · 2014: 38
FWCI: 62.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Neurology (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Society for the Promotion of Science (22229008)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: neuromyelitis optica spectrum disorder, anti-MOG antibodies, aquaporin-4 antibodies, seronegative NMOSD, clinical features, optic neuritis, spinal cord lesions, disease phenotypes, functional recovery, relapse rate
MeSH terms: Adolescent, Adult, Aged, Autoantibodies, Child, Preschool, Female, Humans, Male, Middle Aged, Neuromyelitis Optica, Phenotype, Sex Factors, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks